Prot #JBT101-SSc-002: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

Project: Research project

StatusActive
Effective start/end date11/9/1811/9/21

Funding

  • Corbus Pharmaceuticals, Inc. (Prot #JBT101-SSc-002)